Biochemical Reagent
-
BA6063 HS271Summary: HS271 is a potent, orally effective, selective inhibitor. - BA6064 IRAK4-IN-22Summary: IRAK4-IN-22 (compound 18) is an orally effective and selective potent inhibitor.
- BA6065 IRAK4-IN-14Summary: IRAK4-IN-14 is a potent and selective inhibitor with oral activity.
- BA6066 LarotinibSummary: Larotinib is a potent, broad-spectrum, orally active tyrosine kinase inhibitor (TKI).
- BA6067 IRAK4-IN-20Summary: IRAK4-IN-20 is an orally active inhibitor.
- BA6068 AvoralstatSummary: Avoralstat (BCX4161) is an effective.
- BA6069 SebetralstatSummary: It can be used in the study of metabolic diseases.
- BA6070 BerotralstatSummary: Berotralstat (BCX7353) is a low-toxicity, potent, highly specific, second-generation, orally active inhibitor for hereditary angioedema (HAE).
- BA6071 LanadelumabSummary: Lanadelumab (SHP643) is a human monoclonal antibody against plasma kinin releasing enzyme.
- BA6072 PKSI-527Summary: PKSI-527 is a novel, highly selective plasma kinin release enzyme inhibitor.